In a significant move to bridge the gap between clinical data and the lived experience of illness, the prestigious medical journal Annals of Medicine, published by Taylor & Francis, has issued a formal call for papers for a new, specialized Article Collection titled "Patient Perspectives in Oncology."
As oncology continues to evolve with rapid advancements in targeted therapies, immunotherapy, and genetic sequencing, the medical community is increasingly acknowledging that clinical efficacy—while vital—is only one metric of success. This initiative seeks to elevate the "patient voice," prioritizing the subjective experience of cancer, the psychological impact of treatment, and the navigation of healthcare systems from the perspective of those directly affected.
Main Facts: A Call for Comprehensive Oncology Research
The Annals of Medicine initiative represents a multidisciplinary effort to curate a body of literature that examines cancer care through a humanistic lens. The collection aims to move beyond traditional clinical benchmarks like progression-free survival or objective response rates, instead focusing on how patients navigate the complexities of life with cancer.
The journal is inviting submissions that employ a wide range of methodologies. Unlike specialized journals that may favor quantitative data exclusively, this Article Collection explicitly welcomes:
- Qualitative research: Phenomenological studies, interviews, and ethnographic accounts of the cancer journey.
- Quantitative research: Validated patient-reported outcome measures (PROMs) and quality-of-life assessments.
- Mixed-methods approaches: Integrating statistical data with personal narratives to provide a holistic view.
- Systematic reviews: Synthesizing existing evidence on patient-centered care models.
- Clinical trials: Specifically those designed with patient-centered outcomes as primary or secondary endpoints.
- Study protocols and commentaries: Offering prospective insights into future research directions and critical discourse on current standard-of-care models.
All submissions will be subject to the journal’s rigorous, high-standard peer-review process, ensuring that the work meets the scientific integrity expected of Annals of Medicine.
Chronology: The Road to the 2027 Submission Deadline
The initiative has been structured with a generous timeline to allow for high-quality, longitudinal research and the completion of rigorous clinical trials.
- The Announcement (Current Phase): Taylor & Francis has officially opened the portal for submissions, inviting researchers, clinicians, and social scientists to propose their work.
- Development Phase (2025–2026): Researchers are encouraged to finalize their data collection and draft manuscripts. During this period, potential contributors are advised to maintain close contact with the editorial team, particularly Commissioning Editor Francis Straw, regarding specific submission inquiries or potential Article Processing Charge (APC) discounts.
- Editorial Review Period: Manuscripts will be evaluated on a rolling basis by the Guest Advisors—both of whom hold positions as Associate Editors for Annals of Medicine—ensuring that the collection is curated with clinical expertise.
- The Submission Deadline (May 28th, 2027): This serves as the final cutoff for all submissions to be considered for inclusion in the formal Article Collection.
- Publication Phase: Following the deadline, accepted works will be compiled and promoted as a centralized resource for the medical community, providing a comprehensive repository of patient-centered oncological research.
Supporting Data: Why Patient Perspectives Matter
The shift toward patient-centered oncology is not merely a trend; it is a clinical necessity backed by mounting evidence. Historically, oncological research has been driven by the "three pillars" of efficacy, toxicity, and survival. However, data from the last decade suggests that these pillars often fail to capture the holistic impact of treatment on a patient’s life.
For instance, studies have shown that there is often a significant discrepancy between clinician-reported toxicity (which tends to focus on physical symptoms) and patient-reported toxicity (which captures the impact on daily functioning, cognitive health, and mental well-being).
Furthermore, the rise of "survivorship research" has highlighted that the end of active treatment—often seen as a "success" in clinical data—is frequently the beginning of a new set of challenges, including "scanxiety," long-term cognitive side effects, and the financial toxicity of cancer care. By aggregating research into this new Article Collection, Annals of Medicine intends to provide evidence-based strategies for clinicians to better address these issues, potentially improving treatment adherence and overall patient satisfaction.
Official Responses and Editorial Oversight
The editorial team for this collection is comprised of seasoned Associate Editors from Annals of Medicine, ensuring that the submissions are not only academically sound but also clinically relevant.
Commissioning Editor Francis Straw has emphasized that the collection is intended to be inclusive of the diverse global landscape of oncology. "The patient journey is not monolithic," notes the editorial team. "It is influenced by geography, socioeconomic status, cultural background, and the specific biology of the malignancy."
For those interested in contributing, the journal has provided a clear roadmap. Prospective authors are urged to review the Annals of Medicine journal scope and the specific author submission instructions found on the Taylor & Francis website. The editorial office has also signaled that they are open to discussing the nuances of Article Processing Charges (APCs), recognizing that financial barriers can sometimes discourage researchers in underfunded areas or those representing patient advocacy groups from contributing to high-impact journals.
Implications: Changing the Paradigm of Cancer Care
The implications of this initiative for the medical community are profound. By institutionalizing the inclusion of "Patient Perspectives," Annals of Medicine is setting a new standard for what constitutes "high-quality" research.
1. Influencing Clinical Guidelines
When research is published in a top-tier journal, it often informs the development of future clinical practice guidelines. By centralizing research on how patients perceive and cope with treatment, the collection could influence how oncologists discuss side effects, choose between therapeutic options, and structure supportive care services.
2. Enhancing Shared Decision-Making
Shared decision-making (SDM) is the gold standard of modern oncology, yet it is often hampered by a lack of data regarding what matters most to patients. This collection aims to provide the raw materials—the qualitative and quantitative insights—that clinicians need to facilitate more transparent and empathetic conversations with their patients.
3. Improving Treatment Adherence
Evidence suggests that when patients feel their preferences, fears, and life circumstances are integrated into their treatment plan, adherence rates increase. This research collection could serve as a foundational text for practitioners looking to build more collaborative care models that respect the patient’s agency.
4. Bridging the Gap Between Academia and Advocacy
By inviting submissions that include patient-centered outcomes, the journal is opening its doors to a wider range of contributors, including social workers, psychologists, and patient advocacy groups. This cross-pollination of disciplines is essential for addressing the multifaceted nature of cancer care.
Final Thoughts: A Call to Action
The "Patient Perspectives in Oncology" collection is more than a list of articles; it is an invitation to redefine the purpose of oncology research. As we look toward the 2027 deadline, the medical community has a rare opportunity to contribute to a repository of knowledge that honors the humanity behind the diagnosis.
For researchers, clinicians, and those involved in the supportive care of cancer patients, this is an opportunity to contribute to a shift that is long overdue. Whether your work focuses on the psychological impact of clinical trials, the nuances of palliative care communication, or the socioeconomic barriers to accessing modern oncology treatments, your perspective is needed.
For further information, inquiries regarding submission, or to discuss the alignment of your research with the journal’s goals, please contact the editorial team through the official Taylor & Francis submission portal. As the oncology landscape continues to shift, initiatives like this ensure that the human element remains at the center of the conversation.
About the Author
